How to reduce morbidity and mortality from chest infections in rheumatoid arthritis
- PMID: 20849003
- PMCID: PMC4952158
- DOI: 10.7861/clinmedicine.10-4-326
How to reduce morbidity and mortality from chest infections in rheumatoid arthritis
Abstract
Morbidity and mortality from pneumonia is increased in patients with rheumatoid arthritis. Factors contributing to this have been recently identified and a number of recommendations have been implemented in an attempt to reverse this trend. The present paper shows that these measures have combined to produce a fourfold reduction in both admissions and case fatality rates. In the study population, immunisation rates against influenza and pneumococcus have improved to 86% and 65%, oral steroid consumption has halved and disease modifying drugs were usually appropriately suspended during acute infection. These measures may now merit more widespread adoption.
References
-
- Young A, Koduri G, Batley M, et al. Mortality in rheumatoid arthritis is increased early in the course of disease, as a result of ischaemic heart disease and pulmonary fibrosis. Rheumatology 2007;46:350–7. - PubMed
-
- Coyne P, Hamilton J, Heycock C, et al. Acute lower respiratory tract infections in patients with rheumatoid arthritis. J Rheumatology 2007;34:1832–7. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
